Walden Group Healthcare M&A Blog

Sweeping New EU Regulations, Taking Effect in 2020, Will Create Upheavals in The European Medtech and IVD Markets

07/11/2018
Starting in 2020 medtech firms will be competing in a significantly more complicated European market. New Medical Devices Regulations (MDR) were written to strengthen device safety standards but they will make it far more onerous and expensive for medtech firms to market their products in Europe. Because of the MDR, many smaller companies may...
Read More
Novartis, Abbott, GE, Siemens, and Other Healthcare Giants Are Reversing Previous Diversification Strategies

07/11/2018
Novartis/Alcon After assessing strategic options for Alcon, Novartis is spin-ning it out to shareholders. As a result, both companies will now rivet on their core strengths –pharmaceuticals and oph-thalmic devices, respectively. When Novartis acquired Alcon in 2011 for $52b, the business included surgical, vision care and ophthalmic...
Read More
Sivantos and Widex Announce Merger

05/31/2018
Sivantos, a Germany-based hearing aid maker previously owned by Siemens will merge with Widex, a Denmark-based hearing aid maker to form a company with an enterprise value of more than $8b. Sivantos, owned by EQT Partners, and Widex are merging to form the 3rd largest hearing aid maker. The merger will likely push back EQT’s plans for an...
Read More
As part of J&J's de-diversifying, it is selling its Advanced Sterilization Products (ASP) business to Fortive Corportion (a Danaher spinout)

06/14/2018
Fortive Corporation, a $6.86b diversified conglomerate spinout from Danaher, is acquiring Johnson & Johnson's Advanced Sterilization Products (ASP) business for $2.8b. ASP provides sterilization and disinfection systems and low-temperature hydrogen peroxide sterilization technology. ASP’s products include the STERRAD system for...
Read More
Boston Scientific Announces Acquisition Of nVision Medical Corporation

04/17/2018
Boston Scientific Corporation, a $8.83b manufacturer of medical devices for cardiovascular, digestive, pulmonary and other interventional specialties is acquiring nVision Medical, a developer of a device for collecting cells from the fallopian tubes to detect ovarian cancer. Ovarian cancer is the fifth leading cause of cancer death among women....
Read More